# Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease

> **NCT00584025** · PHASE4 · WITHDRAWN · sponsor: **University of South Florida**

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** levetiracetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00584025
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-12
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study withdrawn due to personnel limitations.
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00584025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00584025, "Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00584025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*